Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jun Toyohara; Mohammed Al-Qahtani; Ya Yao Huang; Emiliano Cazzola; Sergio Todde; Shozo Furumoto; Renata Mikolajczak; Clemens Decristoforo; Nic Gillings; Min Yang; Raymond Reilly; Adriano Duatti; Antonia Denkova; Ralf Schirrmacher; Giuseppe Carlucci; Yann Seimbille; Zhaofei Liu; Beverley Ellis; Bart T. Cornelissen; Klaus Kopka; Emerson Bernardes

doi:10.1186/s41181-022-00177-w

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jun Toyohara, Mohammed Al-Qahtani, Ya Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, Clemens Decristoforo, Nic Gillings, Min Yang, Raymond Reilly, Adriano Duatti, Antonia Denkova, Ralf Schirrmacher, Giuseppe Carlucci, Yann Seimbille, Zhaofei Liu, Beverley Ellis, Bart T. Cornelissen, Klaus Kopka^*Emerson Bernardes

^*Corresponding author for this work

Radiology & Nuclear Medicine

Research output: Contribution to journal › Review article › Academic › peer-review

7 Downloads (Pure)

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

Original language	English
Article number	25
Journal	EJNMMI Radiopharmacy and Chemistry
Volume	7
Issue number	1
DOIs	https://doi.org/10.1186/s41181-022-00177-w
Publication status	Published - 1 Oct 2022

Bibliographical note

Funding
Open Access funding enabled and organized by Projekt DEAL.

Publisher Copyright: © 2022, The Author(s).

Access to Document

10.1186/s41181-022-00177-wLicence: CC BY

s41181-022-00177-wFinal published version, 1.52 MBLicence: CC BY

Cite this

Toyohara, J., Al-Qahtani, M., Huang, Y. Y., Cazzola, E., Todde, S., Furumoto, S., Mikolajczak, R., Decristoforo, C., Gillings, N., Yang, M., Reilly, R., Duatti, A., Denkova, A., Schirrmacher, R., Carlucci, G., Seimbille, Y., Liu, Z., Ellis, B., Cornelissen, B. T., ... Bernardes, E. (2022). Highlight selection of radiochemistry and radiopharmacy developments by editorial board. EJNMMI Radiopharmacy and Chemistry, 7(1), Article 25. https://doi.org/10.1186/s41181-022-00177-w

@article{6d73d54a9a4f47c7a85a35d87fbce863,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board",

abstract = "Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.",

author = "Jun Toyohara and Mohammed Al-Qahtani and Huang, {Ya Yao} and Emiliano Cazzola and Sergio Todde and Shozo Furumoto and Renata Mikolajczak and Clemens Decristoforo and Nic Gillings and Min Yang and Raymond Reilly and Adriano Duatti and Antonia Denkova and Ralf Schirrmacher and Giuseppe Carlucci and Yann Seimbille and Zhaofei Liu and Beverley Ellis and Cornelissen, {Bart T.} and Klaus Kopka and Emerson Bernardes",

note = "Funding Open Access funding enabled and organized by Projekt DEAL. Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = oct,

day = "1",

doi = "10.1186/s41181-022-00177-w",

language = "English",

volume = "7",

journal = "EJNMMI Radiopharmacy and Chemistry",

issn = "2365-421X",

publisher = "Springer Science+Business Media",

number = "1",

}

Toyohara, J, Al-Qahtani, M, Huang, YY, Cazzola, E, Todde, S, Furumoto, S, Mikolajczak, R, Decristoforo, C, Gillings, N, Yang, M, Reilly, R, Duatti, A, Denkova, A, Schirrmacher, R, Carlucci, G, Seimbille, Y, Liu, Z, Ellis, B, Cornelissen, BT, Kopka, K & Bernardes, E 2022, 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board', EJNMMI Radiopharmacy and Chemistry, vol. 7, no. 1, 25. https://doi.org/10.1186/s41181-022-00177-w

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board

AU - Toyohara, Jun

AU - Al-Qahtani, Mohammed

AU - Huang, Ya Yao

AU - Cazzola, Emiliano

AU - Todde, Sergio

AU - Furumoto, Shozo

AU - Mikolajczak, Renata

AU - Decristoforo, Clemens

AU - Gillings, Nic

AU - Yang, Min

AU - Reilly, Raymond

AU - Duatti, Adriano

AU - Denkova, Antonia

AU - Schirrmacher, Ralf

AU - Carlucci, Giuseppe

AU - Seimbille, Yann

AU - Liu, Zhaofei

AU - Ellis, Beverley

AU - Cornelissen, Bart T.

AU - Kopka, Klaus

AU - Bernardes, Emerson

PY - 2022/10/1

Y1 - 2022/10/1

N2 - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

AB - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

UR - http://www.scopus.com/inward/record.url?scp=85139381904&partnerID=8YFLogxK

U2 - 10.1186/s41181-022-00177-w

DO - 10.1186/s41181-022-00177-w

M3 - Review article

AN - SCOPUS:85139381904

SN - 2365-421X

VL - 7

JO - EJNMMI Radiopharmacy and Chemistry

JF - EJNMMI Radiopharmacy and Chemistry

IS - 1

M1 - 25

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this